Abstract
Objective. To investigate the nature of osteopenia/osteoporosis in spondyloarthropathy, an inflammatory disorder, using the HLA-B27 transgenic rat model. Methods. HLA-B27 transgenic rats were housed individually and sacrificed at the peak of their disease (8-month-old). The spine and femurs were removed and stored in saline at -20°C until analysis. The bone structure and strength were determined using a micro-computed tomography (micro-CT) device (Scanco Medical) and mechanical testing (Instron 5543). Vertebral bodies and femurs were scanned to determine trabecular structural properties in terms of bone volume (BV/TV), trabecular thickness, and spacing. After scanning, the mid-shaft femurs were subjected to a 3-point bending test (along anterior-posterior direction), the femoral necks were tested in bending, and the vertebral bodies (L4) were tested in compression. Structural (ultimate/yield load, stiffness) and apparent material (ultimate/yield stress, modulus) strength parameters were then determined. Results. The majority of the bone structural and strength parameters were significantly lower (P <0.05) in the HLA-B27 transgenic rats as compared with control littermates. Micro-CT data suggested that the transgenic animals had lower BV/TV and trabecular thickness in their vertebral bodies. The poor trabecular structure observed in HLA-B27 rats is also indicative of the poor biomechanical strength properties in the vertebral bodies as well. Conclusion. The HLA-B27 transgenic rats develop bone fragility similar to that seen in spondyloarthropathy and may be an important model for the study of osteoporosis in spondyloarthropathy.
| Original language | English |
|---|---|
| Pages (from-to) | 1258-1262 |
| Number of pages | 5 |
| Journal | Rheumatology |
| Volume | 46 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2007 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Neuroscience(all)
- Rheumatology
Cite this
Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy. / Akhter, Mohammed P.; Jung, L. K L.
In: Rheumatology, Vol. 46, No. 8, 08.2007, p. 1258-1262.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy
AU - Akhter, Mohammed P.
AU - Jung, L. K L
PY - 2007/8
Y1 - 2007/8
N2 - Objective. To investigate the nature of osteopenia/osteoporosis in spondyloarthropathy, an inflammatory disorder, using the HLA-B27 transgenic rat model. Methods. HLA-B27 transgenic rats were housed individually and sacrificed at the peak of their disease (8-month-old). The spine and femurs were removed and stored in saline at -20°C until analysis. The bone structure and strength were determined using a micro-computed tomography (micro-CT) device (Scanco Medical) and mechanical testing (Instron 5543). Vertebral bodies and femurs were scanned to determine trabecular structural properties in terms of bone volume (BV/TV), trabecular thickness, and spacing. After scanning, the mid-shaft femurs were subjected to a 3-point bending test (along anterior-posterior direction), the femoral necks were tested in bending, and the vertebral bodies (L4) were tested in compression. Structural (ultimate/yield load, stiffness) and apparent material (ultimate/yield stress, modulus) strength parameters were then determined. Results. The majority of the bone structural and strength parameters were significantly lower (P <0.05) in the HLA-B27 transgenic rats as compared with control littermates. Micro-CT data suggested that the transgenic animals had lower BV/TV and trabecular thickness in their vertebral bodies. The poor trabecular structure observed in HLA-B27 rats is also indicative of the poor biomechanical strength properties in the vertebral bodies as well. Conclusion. The HLA-B27 transgenic rats develop bone fragility similar to that seen in spondyloarthropathy and may be an important model for the study of osteoporosis in spondyloarthropathy.
AB - Objective. To investigate the nature of osteopenia/osteoporosis in spondyloarthropathy, an inflammatory disorder, using the HLA-B27 transgenic rat model. Methods. HLA-B27 transgenic rats were housed individually and sacrificed at the peak of their disease (8-month-old). The spine and femurs were removed and stored in saline at -20°C until analysis. The bone structure and strength were determined using a micro-computed tomography (micro-CT) device (Scanco Medical) and mechanical testing (Instron 5543). Vertebral bodies and femurs were scanned to determine trabecular structural properties in terms of bone volume (BV/TV), trabecular thickness, and spacing. After scanning, the mid-shaft femurs were subjected to a 3-point bending test (along anterior-posterior direction), the femoral necks were tested in bending, and the vertebral bodies (L4) were tested in compression. Structural (ultimate/yield load, stiffness) and apparent material (ultimate/yield stress, modulus) strength parameters were then determined. Results. The majority of the bone structural and strength parameters were significantly lower (P <0.05) in the HLA-B27 transgenic rats as compared with control littermates. Micro-CT data suggested that the transgenic animals had lower BV/TV and trabecular thickness in their vertebral bodies. The poor trabecular structure observed in HLA-B27 rats is also indicative of the poor biomechanical strength properties in the vertebral bodies as well. Conclusion. The HLA-B27 transgenic rats develop bone fragility similar to that seen in spondyloarthropathy and may be an important model for the study of osteoporosis in spondyloarthropathy.
UR - http://www.scopus.com/inward/record.url?scp=34547840157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547840157&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kem104
DO - 10.1093/rheumatology/kem104
M3 - Article
C2 - 17526927
AN - SCOPUS:34547840157
VL - 46
SP - 1258
EP - 1262
JO - Rheumatology
JF - Rheumatology
SN - 1462-0324
IS - 8
ER -